Pilar Biosciences seeks to make precision medicine a first-line therapy for cancer patients November 2, 2021 Auto Bot Diagnostics, MedCitizens, News, Oncology, Startups 0 Randy Pritchard, Pillar Biosciences CEO, highlighted some of the progress the oncology solutions company has made in developing in-vitro diagnostics in response to emailed questions from MedCity News.